1-(2-(1-(2-methoxyethyl)-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-(pyridin-4-ylmethyl)urea

ID: ALA4877360

PubChem CID: 164626220

Max Phase: Preclinical

Molecular Formula: C19H20N8O2

Molecular Weight: 392.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCn1nccc1-c1nc2ccc(NC(=O)NCc3ccncc3)cn2n1

Standard InChI:  InChI=1S/C19H20N8O2/c1-29-11-10-26-16(6-9-22-26)18-24-17-3-2-15(13-27(17)25-18)23-19(28)21-12-14-4-7-20-8-5-14/h2-9,13H,10-12H2,1H3,(H2,21,23,28)

Standard InChI Key:  JDVBQNXXVMKQMB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   26.8724   -4.9238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5801   -4.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2878   -4.9238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.0019   -4.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1647   -4.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5801   -3.6980    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.4570   -4.9238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7498   -4.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0426   -4.9200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0422   -5.7381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.7548   -6.1465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4592   -5.7362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7046   -4.9212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7068   -3.2877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9950   -3.6945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4144   -3.6985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4111   -4.5152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.1868   -4.7708    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6696   -4.1120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1921   -3.4494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.4795   -4.1076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9584   -4.7576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7274   -4.5032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7230   -3.6932    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9514   -3.4472    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6937   -2.6717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2364   -2.0607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0369   -2.2253    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.2946   -3.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  1  5  1  0
  2  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4 13  2  0
  4 15  1  0
 13 17  1  0
 16 14  1  0
 14 15  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4877360

    ---

Associated Targets(Human)

NAMPT Tchem Nicotinamide phosphoribosyltransferase (3221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.42Molecular Weight (Monoisotopic): 392.1709AlogP: 1.96#Rotatable Bonds: 7
Polar Surface Area: 111.26Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.12CX Basic pKa: 5.02CX LogP: 1.52CX LogD: 1.52
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -2.40

References

1. Akiu M, Tsuji T, Sogawa Y, Terayama K, Yokoyama M, Tanaka J, Asano D, Sakurai K, Sergienko E, Sessions EH, Gardell SJ, Pinkerton AB, Nakamura T..  (2021)  Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition.,  43  [PMID:33887438] [10.1016/j.bmcl.2021.128048]

Source